English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
carboxylic acid/atrophy
The link is saved to the clipboard
Page 1 from 19 results
Mixture of carboxylic acids for treating patients with kidney failure
Only registered users can translate articles
Log In/Sign up
II.1. Chronic renal failure
II.2. Acute renal failure
II.3. Chronic or acute hepatopathy occurring with hyperammonemia
II.4. Congenital diseases with enzymatic alterations of the urea cycle
II.5. Pathological human conditions having negative nitrogen balance, namely:
II.5.1. Sepsis
II.5.2.
2-Phenyl-4-quinoline carboxylic acids
Only registered users can translate articles
Log In/Sign up
BRIEF SUMMARY OF THE INVENTION
This invention is concerned with methods of (a) treating arthritis in a mammal by inhibiting the progressive joint deterioration characteristic of arthritic disease, and (b) inducing immunosuppression in a mammal which comprise administering to said mammal an effective
Use of 2-azabicycloi[2.2.2]octane-3-carboxylic acid derivatives for the treatment of arteritis
Only registered users can translate articles
Log In/Sign up
The present invention relates to the use of 2-azabicyclo[2.2.2]octane-3-carboxylic acid derivatives treatment of vascular diseases.
More specifically, the invention relates to the use for the treatment of diseases resulting from impairment of the vascular wall or of disorders of the
Use of 2-azabicyclo[2.2.2]octane-3-carboxylic acid derivatives for the treatment of migraine
Only registered users can translate articles
Log In/Sign up
The present invention relates to the use of 2-azabicyclo[2.2.2]octane-3-carboxylic acid derivatives for the treatment of vascular diseases.
More specifically, the invention relates to the use, for the treatment of diseases resulting from impairment of the vascular wall or of disorders of the
2-azabicyclo(2,2,2)octane-3-carboxylic acid derivatives for the treatment of disorders of the cerebral circulation
Only registered users can translate articles
Log In/Sign up
The examples which follow illustrate the invention and in no way limit the latter.
EXAMPLE 1
ACTIVITY OF THE PRODUCTS OF FORMULA (I) AT NON-HYPOTENSIVE DOSES ON PLASMA CONVERTING ENZYME
The use of a derivative of formula (I) --having converting enzyme inhibitory properties --in the treatment of
Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
1. Field of the Invention The present invention relates to novel tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidine compounds that are antagonists of alpha V (.alpha.v) integrins, for example .alpha..sub.v.beta..sub.3 and .alpha..sub.v.beta..sub.5 integrins, their
Hydroxamic and carboxylic acid derivatives
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
This invention relates to hydroxamic and carboxylic acid derivatives, and to their use in medicine.
BACKGROUND OF THE INVENTION
Metalloproteinases, including matrix metalloproteinase (MMP), collagenase, gelatinase and TNF.alpha. convertase (TACE), and their modes of action,
Hydroxamic and carboxylic acid derivatives
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
This invention relates to hydroxamic and carboxylic acid derivatives, and to their use in medicine.
BACKGROUND TO THE INVENTION
Metalloproteinases, including matrix metalloproteinase (MMP), collagenase, gelatinase and TNF.alpha. convertase (TACE), and their modes of action,
(4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
The present invention relates to (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamide derivatives, and to pharmaceutical compositions and methods of treatment.
The compounds of the present invention are inhibitors of zinc metalloendopeptidases, especially
Esters and amides of 2,4,6-trialkyl-3-hydroxy-phenylalkanoic acids
Only registered users can translate articles
Log In/Sign up
DETAILED DISCLOSURE
This invention pertains to esters and amides of 2,4,6-trialkyl-3-hydroxyphenylalkanoic acids and to organic materials normally subject to oxidative, thermal and UV light deterioration stabilized with said ester and amide compounds. More specifically, the compounds of this
Surface treated calcium carbonate filler for resin and resin composition containing the filler
Only registered users can translate articles
Log In/Sign up
TECHNICAL FIELD
The present invention relates to a surface treated calcium filler for resins and a resin composition containing the filler. The surface treated calcium filler for resins of the present invention has excellent dispersibility, and therefore when added to a porous film, for example,
Adhesive resin composition and multi-layer laminated structure using the same
Only registered users can translate articles
Log In/Sign up
TECHNICAL FIELD
The present invention relates to an adhesive resin composition which displays excellent initial adhesion and durable adhesion to barrier materials such as saponified products of ethylene-vinyl acetate copolymers, or polyamide based resins, has excellent moldability, and for which
Soldering flux
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a soldering flux.
2. Description of the Related Art
The great majority of soldering fluxes heretofore available comprise a rosin or rosin-modified resin supplemented with an activator consisting of an organic acid and a
Quinoline derivatives and their use as tyrosine kinase inhibitors
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
The present invention relates to quinoline derivatives and to the use thereof in therapy. More particularly, the present invention relates to quinoline derivatives for the treatment of cancer, diabetic retinopathy, age-related macular degeneration, inflammation, stroke,
Electrolytic solution for aluminum electrolyte capacitor, and aluminum electrolyte capacitor using the same
Only registered users can translate articles
Log In/Sign up
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the U.S. national phase application pursuant to 35 U.S.C. .sctn.371 of PCT International Patent Application No. PCT/JP2012/075482, filed Oct. 2, 2012, which claims priority to Japanese Patent Application No. 2011-227077, filed Oct. 14,
The most complete medicinal herbs database backed by science
- Works in 55 languages
- Herbal cures backed by science
- Herbs recognition by image
- Interactive GPS map - tag herbs on location (coming soon)
- Read scientific publications related to your search
- Search medicinal herbs by their effects
- Organize your interests and stay up do date with the news research, clinical trials and patents
Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research
